Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Antibe Therapeutics Inc(Pre-Merger)
ATBPF
Healthcare
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,...
otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:ATBPF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
...
Next
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Jun 22, 2022 10:23am
Back in
sold this morning @64 just got filled @62 3k shares davgro can verify lol. $35 clear profit enough for that burger fries and gas in the car lol
(55)
•••
StockingUp21
X
View Profile
View Bullboard History
Comment by
StockingUp21
on Jun 21, 2022 7:40pm
RE:RE:RE:ATE is in blackout
Stock promoters never block for very long. I have a private bet lets see how long muggoo lasts
(33)
•••
Inthepez
X
View Profile
View Bullboard History
Comment by
Inthepez
on Jun 21, 2022 5:04pm
RE:RE:RE:ATE is on sale
no one believes you....
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Comment by
Duster340
on Jun 21, 2022 3:31pm
RE:RE:ATE is on sale
Duster340 Writes: actually i added back @62 cents, have you not learned anything now is not the time to be flipping, you will not get back in cheaper. only days away from year end financials and
...more
(450)
•••
davgro
X
View Profile
View Bullboard History
Comment by
davgro
on Jun 21, 2022 12:17pm
RE:ATE is on sale
09:51:28 M 0.63 -0.07 3,000 124 Questrade 1 Anonymous Yo Dumpster, there is a large enough bid @ 0.64 for you to flip your
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Jun 21, 2022 11:36am
RE:RE:ATE is in blackout
OK Magic you are right ... enough of the child's play. I'm going to need you guys to slap me if I get into those rediculous back-and-forth arguments over nothing useful and then I'll add
...more
(81)
•••
Stutters
X
View Profile
View Bullboard History
Post by
Stutters
on Jun 21, 2022 11:12am
Some music to liven up this funeral
https://youtu.be/fz5jGKDgBII
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Jun 21, 2022 11:10am
RE:RE:RE:Interesting
Correct ! Never know where the best delivery is going to come from. Here's a 2006 study for Indomethacin re. SARS ... -------------------------- Indomethacin has a potent
...more
(81)
•••
Stutters
X
View Profile
View Bullboard History
Post by
Stutters
on Jun 21, 2022 11:09am
Forestclown
why would Dan tell you he is going to buy? He certianly didnt tell you he was going to sell last fall. Did he?
(81)
•••
Stutters
X
View Profile
View Bullboard History
Post by
Stutters
on Jun 21, 2022 10:34am
Maybe Dan bought those 50 shares this morning
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Jun 21, 2022 9:44am
RE:No one is calling the blackout B.S.
What I'm saying is ... Forestview is correct re. blackout periods and if you look at when purchases were made in the past (which I'm not going to verifty - going by memory) - you might see
...more
(3)
•••
themagicbox
X
View Profile
View Bullboard History
Comment by
themagicbox
on Jun 21, 2022 9:32am
RE:RE:Interesting
Indomethacin, huh. Usually thats prescribed for a gout flare up.
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Jun 21, 2022 9:04am
No one is calling the blackout B.S.
Forestview Wrote: Dan has said he and the leadership team plan to buy after the black out lifts this summer. This is what i am calling B.S. have you heard him say this mugsy? i do
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Jun 21, 2022 8:37am
RE:RE:Interesting
Was compared to Regeneron and to ATB-429 ... looks like 344 came out on top.
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Jun 21, 2022 7:38am
RE:Interesting
Upon further investigation, this is ATB-344 and it's using the NSAID Indomethacin.
Prev
...
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >